eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 04/05/2011
SPC Boots Dual Action Athlete's Foot Spray


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Dual Action Athlete's Foot Spray


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient% quantity
Tolnaftate0.12 w/w

Go to top of the page
3. PHARMACEUTICAL FORM

Dry Powder Spray


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

The product is indicated for the adjunctive treatment and prevention of athlete's foot (tinea pedis). It may also be helpful in conditions where tenderness and sweating cause skin irritation. It is also effective in other conditions, such as dhobie itch (tinea cruris) and prickly heat (miliaria).


Go to top of the page
4.2 Posology and method of administration

Adults, elderly and children over 2 Years

The affected area should be treated morning and night.

Treatment should continue for at least a week after the infection has cleared up.

Children under 2 Years

Not recommended except under the advice and supervision of a doctor

For topical application to the skin.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

If irritation or hypersensitivity occurs or if the condition does not improve within 10 days or becomes worse, treatment should be discontinued and medical advice sought.

Avoid contact with eyes.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

No clinically significant drug interactions known.


Go to top of the page
4.6 Pregnancy and lactation

Safety in pregnancy has not been established. However, no teratogenic effects have been observed in clinical use. In studies in rats and mice, tolnaftate did not exert a deleterious effect on foetal or postnatal development.

If is not known whether topical tolnaftate is secreted into breast milk. However no undesirable effects in breast fed infants whose mothers were using tolnaftate have been reported.


Go to top of the page
4.7 Effects on ability to drive and use machines

No adverse effects known.


Go to top of the page
4.8 Undesirable effects

Skin reactions occur rarely and may include irritation and contact dermatitis.


Go to top of the page
4.9 Overdose

Not applicable.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Tolnaftate is an established antifungal agent which appears to produce its effects through inhibition of sterol synthesis.


Go to top of the page
5.2 Pharmacokinetic properties

No data available.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Talc extra 5/0 - M20 DEC

Denatured ethanol B grade

Disteardimonium hectorite

Dimethyl ether


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

24 months.


Go to top of the page
6.4 Special precautions for storage

Store below 25°C.

Caution: Flammable.

Pressurised container, protect from sunlight and do not expose to temperatures exceeding 50°C.

Do not pierce or burn, even after use.

Do not spray on a naked flame or any incandescent material.

Avoid inhalation.

Do not use near, or place container on, polished or painted surfaces. CFC-Free - does not contain CFC's which damage ozone.


Go to top of the page
6.5 Nature and contents of container

Internally lacquered aluminium can fitted with a continuous spray valve and an actuator.

Pack size: 150 millilitres


Go to top of the page
6.6 Special precautions for disposal and other handling

None.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

The Boots Company PLC

1 Thane Road West

Nottingham NG2 3AA


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 00014/0520


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

26 April 1996.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2001.



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/11223/SPC/


Active Ingredients/Generics

 
   tolnaftate